Volastra Therapeutics Funding: $84M Raised, Series A (2023)
Volastra Therapeutics is based in New York, NY. It has raised $84M in total funding. Latest round: Series A.
Volastra Therapeutics funding overview
Volastra Therapeutics is based in New York, NY. Volastra Therapeutics has raised $84M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Volastra Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Polaris Partners, Vida Ventures, ARCH Venture Partners, DROIA Oncology Ventures, Global Health Sciences (GHS) Fund, Catalio Capital Management and 1 others. 7 distinct backers are named across the disclosed rounds.
Volastra Therapeutics at a glance
Total raised
$84M
Latest round
Series A
Latest round date
March 2023
Headquarters
New York, NY
Notable investors
Polaris Partners, Vida Ventures, ARCH Venture Partners, DROIA Oncology Ventures, Global Health Sciences (GHS) Fund, Catalio Capital Management, Eli Lilly and Company
Frequently asked about Volastra Therapeutics funding
How much has Volastra Therapeutics raised?
Volastra Therapeutics has raised $84M in total disclosed funding across the rounds on record.
Who has invested in Volastra Therapeutics?
Polaris Partners, Vida Ventures, ARCH Venture Partners, DROIA Oncology Ventures, Global Health Sciences (GHS) Fund, Catalio Capital Management are named among the investors backing Volastra Therapeutics.
What was the latest Volastra Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Volastra Therapeutics based?
Volastra Therapeutics is based in New York, NY.
When did Volastra Therapeutics last raise?
The last disclosed Volastra Therapeutics round closed in March 2023 at Series A.
Every Volastra Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.
